Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 2.57 Delayed Data As of Nov 25 |  -0.10 / -3.72%Today’s Change | 1.77 Today|||52-Week Range 11.40 | -71.94% Year-to-Date |
Latest VRCA News | Press Releases
No recent news for Verrica Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.69 |
| Today’s open | 2.68 |
| Day’s range | 2.54 - 2.68 |
| Volume | 12,175 |
| Average volume (3 months) | 106,001 |
| Market cap | $105.6M |
Data as of 12:56pm ET, 11/25/2022
Growth & Valuation
| Earnings growth (last year) | +24.06% |
| Earnings growth (this year) | +29.69% |
| Earnings growth (next 5 years) | -20.18% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 20.64 |
| Price/Book | 2.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VIRXViracta Therapeutics... | +0.15 | +5.70% |
| CLLSCellectis SA | -0.15 | -6.00% |
| GLYCGlycoMimetics Inc | -0.04 | -1.91% |
| TRVITrevi Therapeutics I... | 0.00 | 0.00% |
Data as of 12:58pm ET, 11/25/2022
Financials
| Next reporting date | March 2, 2023 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $12.0M |
| Annual profit (last year) | -$35.1M |
| Net profit margin | -292.33% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters West Chester, Pennsylvania |
Forecasts
